|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
20 September 2021 |
|
Main ID: |
NCT03041662 |
|
Date of registration:
|
01/02/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)
PSC |
|
Scientific title:
|
Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC) |
|
Date of first enrolment:
|
October 31, 2011 |
|
Target sample size:
|
620 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03041662 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Sweden
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosis of PSC by MR/MRCP
- Life expectancy >1 year
- Informed consent
Exclusion Criteria:
- Liver transplantation or on the waiting list
- Secondry SC
- Diagnosis of CCA
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Primary Sclerosing Cholangitis
|
|
Cholangiocarcinoma
|
|
Intervention(s)
|
|
Diagnostic Test: MR/MRCP
|
|
Primary Outcome(s)
|
|
liver transplatation
[Time Frame: 10 yrs f-up]
|
|
cholangiocarcinoma
[Time Frame: 10 yrs f-up]
|
|
death
[Time Frame: 10 yrs f-up]
|
|
Secondary Outcome(s)
|
|
biliary dysplasia
[Time Frame: 10 yrs f-up]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|